ArriVent BioPharma, Inc. AVBP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$43.32M-21.9% | -$35.54M-1.6% | -$34.98M-11.4% | -$31.4M+51.2% | -$64.39M-212% | ||
| -$559K+26.1% | -$756.5K0.0% | -$756.5K0.0% | -$756.5K0.0% | -$756.5K— | ||
| $5.49M+70.2% | $3.22M-13.3% | $3.72M+12.2% | $3.31M+45.8% | $2.27M+139% | ||
| $2.81M— | —— | $1.87M— | —— | $582K+167% | ||
| -$3.83M-186% | $4.43M+4,766% | $91K-98.7% | $7.03M+244% | -$4.88M-264% | ||
| $2.56M— | $0-100% | $6.49M+36.5% | $4.76M+199% | $1.59M+211% | ||
| $47K+1,040% | -$5K+16.7% | -$6K0.0% | -$6K-50.0% | -$4K0.0% | ||
| -$41.89M-36.6% | -$30.66M+14.4% | -$35.8M-37.0% | -$26.12M+61.6% | -$68.01M-321% | ||
| $64.38M-57.4% | $151.18M+67.3% | $90.37M+319% | $21.57M+120% | $9.82M-79.8% | ||
| $67.97M-15.0% | $79.98M+102% | $39.61M+11.6% | $35.48M-23.9% | $46.64M+10,880% | ||
| $3.58M+105% | -$71.2M-40.3% | -$50.76M-465% | $13.91M-62.2% | $36.82M+177% | ||
| $54.72M+57.9% | $34.66M-79.3% | $167.6M— | $0-100% | $6.52M— | ||
| $54.87M+58.0% | $34.73M-59.8% | $86.47M+15.1% | $75.11M+1,011% | $6.76M+12,189% | ||
| $16.56M+125% | -$67.13M-72,085% | -$93K-100% | $62.9M+357% | -$24.43M+88.3% | ||
| $2.81M— | —— | $1.87M— | —— | $582K+167% | ||
| $47K+1,040% | -$5K+16.7% | -$6K0.0% | -$6K-50.0% | -$4K0.0% | ||
| -$37K— | —— | —— | —— | —— | ||
| $2.56M— | $0-100% | $6.49M+36.5% | $4.76M+199% | $1.59M+211% | ||
| $67.97M-15.0% | $79.98M+102% | $39.61M+11.6% | $35.48M-23.9% | $46.64M+10,880% | ||
| —— | $17K— | —— | $303K+506% | $50K— | ||
| $47K+1,040% | -$5K+16.7% | -$6K0.0% | -$6K-50.0% | -$4K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ArriVent BioPharma, Inc. generate?
- ArriVent BioPharma, Inc. (AVBP) generated -$134.5M in operating cash flow over the trailing twelve months.
- Where does ArriVent BioPharma, Inc.'s cash flow data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.